Tetramethylpyrazine-derived polyurethane for improved hemocompatibility and rapid endothelialization.

Area of Science:

• Biomaterials Science
• Vascular Surgery
• Polymer Chemistry

Background:

• Thrombosis and intimal hyperplasia (IH) limit the long-term success of small-diameter vascular grafts (SDVGs).
• Achieving a confluent endothelial cell (EC) layer on elastic surfaces is key to preventing restenosis.
• Vascular graft hemocompatibility is critical for enabling sufficient time for endothelialization.

Purpose of the Study:

• To synthesize a novel tetramethylpyrazine (TMP)-derived polyurethane (PU) material.
• To enhance the hemocompatibility and endothelialization capabilities of SDVGs.
• To evaluate the potential of TMP-containing PU for improving long-term vascular graft patency.

Main Methods:

• Incorporation of TMP moieties into polyurethane backbones.
• Assessment of hemocompatibility through platelet adhesion/activation assays and clotting time measurements.
• In vitro evaluation of human umbilical vein endothelial cell (HUVEC) adhesion, proliferation, and biocompatibility on TMP-PU films.

Main Results:

• TMP-containing PU films demonstrated significantly improved hemocompatibility by reducing platelet adhesion/activation and prolonging clotting time.
• In vitro studies showed that TMP incorporation markedly enhanced HUVEC adhesion and proliferation, accelerating endothelialization.
• The synthesized TMP-PU materials exhibited excellent biocompatibility with HUVECs and possessed adjustable elasticity (1123%) for compliance matching.

Conclusions:

• Tetramethylpyrazine-derived polyurethane offers improved hemocompatibility and accelerated endothelialization for vascular grafts.
• This novel material shows significant potential to overcome limitations of current SDVGs and enhance long-term patency.
• The combination of enhanced biological functions and tunable elasticity makes TMP-PU a promising candidate for clinical applications.